Bank of Montreal’s Moderna MRNA Stock Holding History

Bank of Montreal’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.05M	Sell	40,300 -300	-0.7%	-$14K	﹤0.01%	1659
2025 Q4	$1.2M	Sell	40,600 -8,300	-17%	-$225K	﹤0.01%	1887
2025 Q3	$1.26M	Buy	48,900 +9,000	+23%	+$251K	﹤0.01%	1856
2025 Q2	$1.1M	Buy	+39,900	New	+$1.05M	﹤0.01%	1857
2024 Q1	–	Sell	-29,800	Closed	-$2.97M	–	4177
2023 Q4	$2.97M	Hold	29,800	–	–	﹤0.01%	1505
2023 Q3	$3.42M	Hold	29,800	–	–	﹤0.01%	1445
2023 Q2	$4.01M	Buy	29,800 +28,300	+1,887%	+$3.78M	﹤0.01%	1441
2023 Q1	$231K	Hold	1,500	–	–	﹤0.01%	2931
2022 Q4	$315K	Buy	+1,500	New	+$245K	﹤0.01%	2882
2022 Q3	–	Sell	-9,600	Closed	-$1.4K	–	4291
2022 Q2	$1.4K	Sell	9,600 -487,800	-98%	-$69.7M	﹤0.01%	2099
2022 Q1	$90M	Buy	+497,400	New	+$83.7M	0.04%	291
2021 Q4	–	Sell	-63,500	Closed	-$24.7M	–	3727
2021 Q3	$24.7M	Buy	+63,500	New	+$23.4M	0.01%	823
2020 Q1	–	Sell	-27,400	Closed	-$536K	–	4475
2019 Q4	$536K	Hold	27,400	–	–	﹤0.01%	2629
2019 Q3	$436K	Buy	27,400 +27,300	+27,300%	+$403K	﹤0.01%	2485
2019 Q2	$1K	Buy	+100	New	+$2.15K	﹤0.01%	4800

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of Montreal's MRNA Position: Q1 2026 in Review

Bank of Montreal reduced its Moderna (MRNA) stake by 19% in Q1 2026, selling an estimated $3.3M and leaving 297,803 shares worth $15.1M. The position accounts for 0.01% of the portfolio, ranked #948.

Bank of Montreal first reported a position in MRNA in Q1 2019 and has held it in 29 quarters since. The position peaked at $234M in Q4 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Bank of Montreal held 297,803 shares of Moderna worth $15.1M as of Q1 2026.
Bank of Montreal sold 70,699 Moderna shares in Q1 2026, an estimated $3.3M.
Moderna made up 0.01% of Bank of Montreal's portfolio in Q1 2026, its #948 holding.
Bank of Montreal first reported a position in Moderna in Q1 2019 and has held it in 29 quarters since.
Bank of Montreal's Moderna position peaked at $234M in Q4 2021.
723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.